RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.
President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services is one of several unorthodox appointments rolled out in recent weeks, and investors are scrambling to understand the move’s potential impact on markets.
